https://stock.noler.com/us/stock/nunzia-pharmaceutical-company https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/additional-paid-in-capital https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/amended-reports-10-k https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/amended-reports-10-q https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/basic-shares https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/buybacks-stock-repurchased-value https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/cash https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/cash-and-equivalents https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/cash-and-restricted-cash https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/cash-flow-breakdown https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/commitments-and-contingencies https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/common-stock-value https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/cover-page-shares-outstanding https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/current-assets https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/current-liabilities https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/debt-interest-rate https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/deferred-tax-assets-gross https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/deferred-tax-assets-net https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/deferred-tax-assets-valuation-allowance-current https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/diluted-shares https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/due-to-related-parties-current https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/eps https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/eps-basic https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/financing-cash-flow https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/general-and-administrative-expense https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/income-tax https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/income-taxes-paid https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/income-taxes-paid-2 https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/interest-paid-net https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/investment-owned-at-cost https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/investments https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/investments-in-affiliates-subsidiaries-associates-and-joint-ventures https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/net-income https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/notes-payable https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/operating-cash-flow https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/operating-expenses https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/operating-income https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/operating-loss-carryforwards https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/other-income https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/other-selling-general-and-administrative-expense https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/paid-in-capital-other https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/preferred-shares-facts https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/preferred-stock-shares-authorized https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/preferred-stock-shares-issued https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/prepaid-expense-current https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/proceeds-from-convertible-debt https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/proceeds-from-related-party-debt https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/proceeds-from-stock-issued https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/public-float https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/retained-earnings https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/revenue https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-10-12b https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-10-12g https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-10-k https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-10-q https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-10ksb https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-10ksb40 https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-10qsb https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-15-12g https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-8-k https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/sec-filings-def-14a https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/secondary-offerings-form-rw https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/shareholders-equity https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/shares-issued-shares-new-issues https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/stock-based-compensation https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/stock-issued-new-shares-sold https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/total-assets https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/total-liabilities https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/total-liabilities-and-equity https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/total-long-term-debt https://stock.noler.com/us/stock/nunzia-pharmaceutical-company/weighted-average-number-of-share-outstanding-basic-and-diluted